Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-specific T cells for Glioblastoma (COGLI)
NCT01205334Phase 2Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Nov 2010
- Primary completion
- Jan 2012
- Countries
- 1
01
Overview
A Phase 2 trial of autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes in glioblastoma multiforme (GBM), sponsored by Baylor College of Medicine. Started Nov 2010; status: terminated.
02
Drugs
autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01205334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205334.